<VariationArchive VariationID="11234" VariationName="NM_004006.3(DMD):c.[10086+1G&gt;T;10126del]" VariationType="Haplotype" Accession="VCV000011234" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2017-07-06" MostRecentSubmission="2023-03-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Haplotype VariationID="11234" NumberOfChromosomes="1">
      <SimpleAllele AlleleID="271861" VariationID="287624">
        <GeneList>
          <Gene Symbol="DMD" FullName="dystrophin" GeneID="1756" HGNC_ID="HGNC:2928" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>Xp21.2-21.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="31119222" stop="33339388" display_start="31119222" display_stop="33339388" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="31137344" stop="33357725" display_start="31137344" display_stop="33357725" Strand="-" />
            </Location>
            <OMIM>300377</OMIM>
            <Haploinsufficiency last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
            <Triplosensitivity last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">No evidence available</Triplosensitivity>
          </Gene>
        </GeneList>
        <Name>NM_004006.3(DMD):c.10126del (p.Val3375_Leu3376insTer)</Name>
        <CanonicalSPDI>NC_000023.11:31178765:G:</CanonicalSPDI>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>Xp21.2</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="31178766" stop="31178766" display_start="31178766" display_stop="31178766" variantLength="1" positionVCF="31178765" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="31196883" stop="31196883" display_start="31196883" display_stop="31196883" variantLength="1" positionVCF="31196882" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        </Location>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.31196883del" Assembly="GRCh37">
              <Expression>NC_000023.10:g.31196883del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.31178766del" Assembly="GRCh38">
              <Expression>NC_000023.11:g.31178766del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_012232.1" sequenceAccession="NG_012232" sequenceVersion="1" change="g.2165844del">
              <Expression>NG_012232.1:g.2165844del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_000109.4" sequenceAccession="NM_000109" sequenceVersion="4" change="c.10102del">
              <Expression>NM_000109.4:c.10102del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_000100.3" sequenceAccession="NP_000100" sequenceVersion="3" change="p.Val3367_Leu3368insTer">
              <Expression>NP_000100.3:p.Val3367_Leu3368insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004006.3" sequenceAccession="NM_004006" sequenceVersion="3" change="c.10126del" MANESelect="true">
              <Expression>NM_004006.3:c.10126del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_003997.2" sequenceAccession="NP_003997" sequenceVersion="2" change="p.Val3375_Leu3376insTer">
              <Expression>NP_003997.2:p.Val3375_Leu3376insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004009.3" sequenceAccession="NM_004009" sequenceVersion="3" change="c.10114del">
              <Expression>NM_004009.3:c.10114del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004000.1" sequenceAccession="NP_004000" sequenceVersion="1" change="p.Val3371_Leu3372insTer">
              <Expression>NP_004000.1:p.Val3371_Leu3372insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004010.3" sequenceAccession="NM_004010" sequenceVersion="3" change="c.9757del">
              <Expression>NM_004010.3:c.9757del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004001.1" sequenceAccession="NP_004001" sequenceVersion="1" change="p.Val3252_Leu3253insTer">
              <Expression>NP_004001.1:p.Val3252_Leu3253insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004011.4" sequenceAccession="NM_004011" sequenceVersion="4" change="c.6103del">
              <Expression>NM_004011.4:c.6103del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004002.3" sequenceAccession="NP_004002" sequenceVersion="3" change="p.Val2034_Leu2035insTer">
              <Expression>NP_004002.3:p.Val2034_Leu2035insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004012.4" sequenceAccession="NM_004012" sequenceVersion="4" change="c.6094del">
              <Expression>NM_004012.4:c.6094del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004003.2" sequenceAccession="NP_004003" sequenceVersion="2" change="p.Val2031_Leu2032insTer">
              <Expression>NP_004003.2:p.Val2031_Leu2032insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004013.3" sequenceAccession="NM_004013" sequenceVersion="3" change="c.2746del">
              <Expression>NM_004013.3:c.2746del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004004.2" sequenceAccession="NP_004004" sequenceVersion="2" change="p.Val915_Leu916insTer">
              <Expression>NP_004004.2:p.Val915_Leu916insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004014.3" sequenceAccession="NM_004014" sequenceVersion="3" change="c.1939del">
              <Expression>NM_004014.3:c.1939del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004005.2" sequenceAccession="NP_004005" sequenceVersion="2" change="p.Val646_Leu647insTer">
              <Expression>NP_004005.2:p.Val646_Leu647insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004015.3" sequenceAccession="NM_004015" sequenceVersion="3" change="c.922del">
              <Expression>NM_004015.3:c.922del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004006.1" sequenceAccession="NP_004006" sequenceVersion="1" change="p.Val307_Leu308insTer">
              <Expression>NP_004006.1:p.Val307_Leu308insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004016.3" sequenceAccession="NM_004016" sequenceVersion="3" change="c.922del">
              <Expression>NM_004016.3:c.922del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004007.1" sequenceAccession="NP_004007" sequenceVersion="1" change="p.Val307_Leu308insTer">
              <Expression>NP_004007.1:p.Val307_Leu308insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004017.3" sequenceAccession="NM_004017" sequenceVersion="3" change="c.922del">
              <Expression>NM_004017.3:c.922del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004008.1" sequenceAccession="NP_004008" sequenceVersion="1" change="p.Val307_Leu308insTer">
              <Expression>NP_004008.1:p.Val307_Leu308insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004018.3" sequenceAccession="NM_004018" sequenceVersion="3" change="c.922del">
              <Expression>NM_004018.3:c.922del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004009.1" sequenceAccession="NP_004009" sequenceVersion="1" change="p.Val307_Leu308insTer">
              <Expression>NP_004009.1:p.Val307_Leu308insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004019.3" sequenceAccession="NM_004019" sequenceVersion="3" change="c.922del">
              <Expression>NM_004019.3:c.922del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004010.1" sequenceAccession="NP_004010" sequenceVersion="1" change="p.Val307_Leu308insTer">
              <Expression>NP_004010.1:p.Val307_Leu308insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004020.4" sequenceAccession="NM_004020" sequenceVersion="4" change="c.2746del">
              <Expression>NM_004020.4:c.2746del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004011.3" sequenceAccession="NP_004011" sequenceVersion="3" change="p.Val915_Leu916insTer">
              <Expression>NP_004011.3:p.Val915_Leu916insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004021.3" sequenceAccession="NM_004021" sequenceVersion="3" change="c.2746del">
              <Expression>NM_004021.3:c.2746del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004012.2" sequenceAccession="NP_004012" sequenceVersion="2" change="p.Val915_Leu916insTer">
              <Expression>NP_004012.2:p.Val915_Leu916insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004022.3" sequenceAccession="NM_004022" sequenceVersion="3" change="c.2746del">
              <Expression>NM_004022.3:c.2746del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004013.2" sequenceAccession="NP_004013" sequenceVersion="2" change="p.Val915_Leu916insTer">
              <Expression>NP_004013.2:p.Val915_Leu916insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004023.3" sequenceAccession="NM_004023" sequenceVersion="3" change="c.2746del">
              <Expression>NM_004023.3:c.2746del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004014.2" sequenceAccession="NP_004014" sequenceVersion="2" change="p.Val915_Leu916insTer">
              <Expression>NP_004014.2:p.Val915_Leu916insTer</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_199" sequenceAccession="LRG_199">
              <Expression>LRG_199:g.2165844del</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-12-23" DateCreated="2016-11-29" MostRecentSubmission="2024-02-11" NumberOfSubmissions="4" NumberOfSubmitters="4">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">16770791</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17041906</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">21969337</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25007885</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">27593222</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">7581396</ID>
            </Citation>
            <Citation Type="general">
              <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=DMD</URL>
            </Citation>
            <Citation Type="general">
              <URL>http://www.umd.be/DMD/4DACTION/WV/2598</URL>
            </Citation>
            <ConditionList>
              <TraitSet ID="43348" Type="Finding" ContributesToAggregateClassification="true">
                <Trait ID="27078" Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Calf muscle hypertrophy</ElementValue>
                    <XRef ID="HP:0008981" DB="Human Phenotype Ontology" />
                  </Name>
                  <XRef ID="C1843057" DB="MedGen" />
                  <XRef Type="primary" ID="HP:0008981" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0003703" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0009024" DB="Human Phenotype Ontology" />
                </Trait>
                <Trait ID="27085" Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Proximal muscle weakness in lower limbs</ElementValue>
                    <XRef ID="HP:0008994" DB="Human Phenotype Ontology" />
                  </Name>
                  <XRef ID="C1866010" DB="MedGen" />
                  <XRef Type="primary" ID="HP:0008994" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0002455" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0008941" DB="Human Phenotype Ontology" />
                </Trait>
                <Trait ID="17057" Type="Finding">
                  <Name>
                    <ElementValue Type="Alternate">Motor retardation</ElementValue>
                    <XRef ID="HP:0001270" DB="Human Phenotype Ontology" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">motor developmental delay</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Motor delay</ElementValue>
                    <XRef ID="HP:0001270" DB="Human Phenotype Ontology" />
                  </Name>
                  <XRef ID="C1854301" DB="MedGen" />
                  <XRef Type="primary" ID="HP:0001270" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0001307" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0002130" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0006788" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0006826" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0006909" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0006950" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0006968" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0007219" DB="Human Phenotype Ontology" />
                  <XRef Type="secondary" ID="HP:0007251" DB="Human Phenotype Ontology" />
                </Trait>
              </TraitSet>
              <TraitSet ID="3094" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="10877" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Duchenne muscular dystrophy</ElementValue>
                    <XRef ID="Duchenne+Muscular+Dystrophy/2340" DB="Genetic Alliance" />
                    <XRef ID="MONDO:0010679" DB="MONDO" />
                    <XRef ID="76670001" DB="SNOMED CT" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, pseudohypertrophic progressive, Duchenne type</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">DMD</ElementValue>
                    <XRef Type="MIM" ID="310200" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and DMD-associated dilated cardiomyopathy (DCM). The mild end of the spectrum includes the phenotypes of asymptomatic increase in serum concentration of creatine phosphokinase (CK) and muscle cramps with myoglobinuria. The severe end of the spectrum includes progressive muscle diseases that are classified as Duchenne/Becker muscular dystrophy when skeletal muscle is primarily affected and as DMD-associated DCM when the heart is primarily affected. Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently and standing up from a supine position. Proximal weakness causes a waddling gait and difficulty climbing stairs, running, jumping, and standing up from a squatting position. DMD is rapidly progressive, with affected children being wheelchair dependent by age 12 years. Cardiomyopathy occurs in almost all individuals with DMD after age 18 years. Few survive beyond the third decade, with respiratory complications and progressive cardiomyopathy being common causes of death. Becker muscular dystrophy (BMD) is characterized by later-onset skeletal muscle weakness. With improved diagnostic techniques, it has been recognized that the mild end of the spectrum includes men with onset of symptoms after age 30 years who remain ambulatory even into their 60s. Despite the milder skeletal muscle involvement, heart failure from DCM is a common cause of morbidity and the most common cause of death in BMD. Mean age of death is in the mid-40s. DMD-associated DCM is characterized by left ventricular dilation and congestive heart failure. Females heterozygous for a DMD pathogenic variant are at increased risk for DCM.</Attribute>
                    <XRef ID="NBK1119" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="6291" />
                    <XRef ID="6291" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="general" Abbrev="Updated, AAN/CNS, 2005">
                    <ID Source="PubMed">15642897</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="AAP, 2005">
                    <ID Source="PubMed">16322188</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="DMD Management and Anesthesia - ACCP, 2007">
                    <ID Source="PubMed">18079231</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                    <ID Source="PubMed">19945913</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                    <ID Source="PubMed">19945914</ID>
                  </Citation>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301298</ID>
                    <ID Source="BookShelf">NBK1119</ID>
                  </Citation>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301604</ID>
                    <ID Source="BookShelf">NBK1431</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC Respiratory Panel, 2010">
                    <ID Source="PubMed">20597083</ID>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                    <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_DuchenneMuscularDystrophy-enPro13913.pdf</URL>
                    <CitationText>Orphanet, Duchenne muscular dystrophy, 2013</CitationText>
                  </Citation>
                  <Citation Type="general" Abbrev="AAN, 2022">
                    <ID Source="PubMed">26833937</ID>
                    <ID Source="pmc">4773944</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                    <ID Source="PubMed">29395990</ID>
                    <ID Source="pmc">5889091</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                    <ID Source="PubMed">29398641</ID>
                    <ID Source="pmc">5902408</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                    <ID Source="PubMed">29395989</ID>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                    <URL>https://www.acmg.net/PDFLibrary/DMD_Pathogenic_Variants.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Pathogenic Variant in Dystrophin (DMD Gene) and elevated creatine kinase muscle isoform (CK-MM), Duchenne and Becker Muscular Dystrophy, 2019</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                    <URL>https://www.acmg.net/PDFLibrary/DMD_CKMM.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated creatine kinase muscle isoform (CKMM), Genetic Neuromuscular Disease, 2020</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                    <URL>https://www.acmg.net/PDFLibrary/DMD-Elevated-CKMM-Algorithm.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Algorithm, ELEVATED CREATINEKINASE(CK)-MM , Genetic Neuromuscular Disorders, 2022</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                    <URL>https://www.acmg.net/PDFLibrary/DMD_No_Pathogenic_Variant.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, No Pathogenic Variant in Dystrophin (DMD) Gene after elevated creatine kinase muscle isoform (CK-MM), Genetic Neuromuscular Disease, 2020</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                    <URL>https://www.acmg.net/PDFLibrary/Duchenne-Becker-Muscular-Dystrophy.pdf</URL>
                    <CitationText>American College of Medical Genetics &amp;amp; Genomics Genetic Testing ACT Sheet, Duchenne and Becker Muscular Dystrophy, 2012</CitationText>
                  </Citation>
                  <XRef ID="98896" DB="Orphanet" />
                  <XRef ID="C0013264" DB="MedGen" />
                  <XRef ID="MONDO:0010679" DB="MONDO" />
                  <XRef Type="MIM" ID="310200" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="11234" DB="ClinVar" />
          <XRef ID="CA10605812" DB="ClinGen" />
          <XRef ID="DMD_000063" DB="LOVD 3" />
          <XRef Type="Allelic variant" ID="300377.0024" DB="OMIM" />
          <XRef Type="rs" ID="886043676" DB="dbSNP" />
        </XRefList>
      </SimpleAllele>
      <SimpleAllele AlleleID="492519" VariationID="501095">
        <GeneList>
          <Gene Symbol="DMD" FullName="dystrophin" GeneID="1756" HGNC_ID="HGNC:2928" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>Xp21.2-21.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="31119222" stop="33339388" display_start="31119222" display_stop="33339388" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="31137344" stop="33357725" display_start="31137344" display_stop="33357725" Strand="-" />
            </Location>
            <OMIM>300377</OMIM>
            <Haploinsufficiency last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
            <Triplosensitivity last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">No evidence available</Triplosensitivity>
          </Gene>
        </GeneList>
        <Name>NM_004006.3(DMD):c.10086+1G&gt;T</Name>
        <CanonicalSPDI>NC_000023.11:31180368:C:A</CanonicalSPDI>
        <VariantType>single nucleotide variant</VariantType>
        <Location>
          <CytogeneticLocation>Xp21.2</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="31180369" stop="31180369" display_start="31180369" display_stop="31180369" variantLength="1" positionVCF="31180369" referenceAlleleVCF="C" alternateAlleleVCF="A" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="31198486" stop="31198486" display_start="31198486" display_stop="31198486" variantLength="1" positionVCF="31198486" referenceAlleleVCF="C" alternateAlleleVCF="A" />
        </Location>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.31198486C&gt;A" Assembly="GRCh37">
              <Expression>NC_000023.10:g.31198486C&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.31180369C&gt;A" Assembly="GRCh38">
              <Expression>NC_000023.11:g.31180369C&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_012232.1" sequenceAccession="NG_012232" sequenceVersion="1" change="g.2164241G&gt;T">
              <Expression>NG_012232.1:g.2164241G&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_000109.4" sequenceAccession="NM_000109" sequenceVersion="4" change="c.10062+1G&gt;T">
              <Expression>NM_000109.4:c.10062+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004006.3" sequenceAccession="NM_004006" sequenceVersion="3" change="c.10086+1G&gt;T" MANESelect="true">
              <Expression>NM_004006.3:c.10086+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004011.4" sequenceAccession="NM_004011" sequenceVersion="4" change="c.6063+1G&gt;T">
              <Expression>NM_004011.4:c.6063+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004012.4" sequenceAccession="NM_004012" sequenceVersion="4" change="c.6054+1G&gt;T">
              <Expression>NM_004012.4:c.6054+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004023.3" sequenceAccession="NM_004023" sequenceVersion="3" change="c.2706+1G&gt;T">
              <Expression>NM_004023.3:c.2706+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004020.4" sequenceAccession="NM_004020" sequenceVersion="4" change="c.2706+1G&gt;T">
              <Expression>NM_004020.4:c.2706+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004022.3" sequenceAccession="NM_004022" sequenceVersion="3" change="c.2706+1G&gt;T">
              <Expression>NM_004022.3:c.2706+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004021.3" sequenceAccession="NM_004021" sequenceVersion="3" change="c.2706+1G&gt;T">
              <Expression>NM_004021.3:c.2706+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004013.3" sequenceAccession="NM_004013" sequenceVersion="3" change="c.2706+1G&gt;T">
              <Expression>NM_004013.3:c.2706+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004014.3" sequenceAccession="NM_004014" sequenceVersion="3" change="c.1899+1G&gt;T">
              <Expression>NM_004014.3:c.1899+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004018.3" sequenceAccession="NM_004018" sequenceVersion="3" change="c.882+1G&gt;T">
              <Expression>NM_004018.3:c.882+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004017.3" sequenceAccession="NM_004017" sequenceVersion="3" change="c.882+1G&gt;T">
              <Expression>NM_004017.3:c.882+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004016.3" sequenceAccession="NM_004016" sequenceVersion="3" change="c.882+1G&gt;T">
              <Expression>NM_004016.3:c.882+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004015.3" sequenceAccession="NM_004015" sequenceVersion="3" change="c.882+1G&gt;T">
              <Expression>NM_004015.3:c.882+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004009.3" sequenceAccession="NM_004009" sequenceVersion="3" change="c.10074+1G&gt;T">
              <Expression>NM_004009.3:c.10074+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004010.3" sequenceAccession="NM_004010" sequenceVersion="3" change="c.9717+1G&gt;T">
              <Expression>NM_004010.3:c.9717+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004019.3" sequenceAccession="NM_004019" sequenceVersion="3" change="c.882+1G&gt;T">
              <Expression>NM_004019.3:c.882+1G&gt;T</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_199" sequenceAccession="LRG_199">
              <Expression>LRG_199:g.2164241G&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2021-02-09" DateCreated="2018-03-28" MostRecentSubmission="2024-02-11" NumberOfSubmissions="3" NumberOfSubmitters="3">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">7581396</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">8589698</ID>
            </Citation>
            <Citation Type="general">
              <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=DMD</URL>
            </Citation>
            <ConditionList>
              <TraitSet ID="3094" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="10877" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Duchenne muscular dystrophy</ElementValue>
                    <XRef ID="Duchenne+Muscular+Dystrophy/2340" DB="Genetic Alliance" />
                    <XRef ID="MONDO:0010679" DB="MONDO" />
                    <XRef ID="76670001" DB="SNOMED CT" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Muscular dystrophy, pseudohypertrophic progressive, Duchenne type</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">DMD</ElementValue>
                    <XRef Type="MIM" ID="310200" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="6291" />
                    <XRef ID="6291" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and DMD-associated dilated cardiomyopathy (DCM). The mild end of the spectrum includes the phenotypes of asymptomatic increase in serum concentration of creatine phosphokinase (CK) and muscle cramps with myoglobinuria. The severe end of the spectrum includes progressive muscle diseases that are classified as Duchenne/Becker muscular dystrophy when skeletal muscle is primarily affected and as DMD-associated DCM when the heart is primarily affected. Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently and standing up from a supine position. Proximal weakness causes a waddling gait and difficulty climbing stairs, running, jumping, and standing up from a squatting position. DMD is rapidly progressive, with affected children being wheelchair dependent by age 12 years. Cardiomyopathy occurs in almost all individuals with DMD after age 18 years. Few survive beyond the third decade, with respiratory complications and progressive cardiomyopathy being common causes of death. Becker muscular dystrophy (BMD) is characterized by later-onset skeletal muscle weakness. With improved diagnostic techniques, it has been recognized that the mild end of the spectrum includes men with onset of symptoms after age 30 years who remain ambulatory even into their 60s. Despite the milder skeletal muscle involvement, heart failure from DCM is a common cause of morbidity and the most common cause of death in BMD. Mean age of death is in the mid-40s. DMD-associated DCM is characterized by left ventricular dilation and congestive heart failure. Females heterozygous for a DMD pathogenic variant are at increased risk for DCM.</Attribute>
                    <XRef ID="NBK1119" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="general" Abbrev="Updated, AAN/CNS, 2005">
                    <ID Source="PubMed">15642897</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="AAP, 2005">
                    <ID Source="PubMed">16322188</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="DMD Management and Anesthesia - ACCP, 2007">
                    <ID Source="PubMed">18079231</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                    <ID Source="PubMed">19945913</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                    <ID Source="PubMed">19945914</ID>
                  </Citation>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301298</ID>
                    <ID Source="BookShelf">NBK1119</ID>
                  </Citation>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301604</ID>
                    <ID Source="BookShelf">NBK1431</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC Respiratory Panel, 2010">
                    <ID Source="PubMed">20597083</ID>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                    <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_DuchenneMuscularDystrophy-enPro13913.pdf</URL>
                    <CitationText>Orphanet, Duchenne muscular dystrophy, 2013</CitationText>
                  </Citation>
                  <Citation Type="general" Abbrev="AAN, 2022">
                    <ID Source="PubMed">26833937</ID>
                    <ID Source="pmc">4773944</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                    <ID Source="PubMed">29395990</ID>
                    <ID Source="pmc">5889091</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                    <ID Source="PubMed">29398641</ID>
                    <ID Source="pmc">5902408</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                    <ID Source="PubMed">29395989</ID>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                    <URL>https://www.acmg.net/PDFLibrary/DMD_Pathogenic_Variants.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Pathogenic Variant in Dystrophin (DMD Gene) and elevated creatine kinase muscle isoform (CK-MM), Duchenne and Becker Muscular Dystrophy, 2019</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                    <URL>https://www.acmg.net/PDFLibrary/DMD_CKMM.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated creatine kinase muscle isoform (CKMM), Genetic Neuromuscular Disease, 2020</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                    <URL>https://www.acmg.net/PDFLibrary/DMD-Elevated-CKMM-Algorithm.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Algorithm, ELEVATED CREATINEKINASE(CK)-MM , Genetic Neuromuscular Disorders, 2022</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                    <URL>https://www.acmg.net/PDFLibrary/DMD_No_Pathogenic_Variant.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, No Pathogenic Variant in Dystrophin (DMD) Gene after elevated creatine kinase muscle isoform (CK-MM), Genetic Neuromuscular Disease, 2020</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                    <URL>https://www.acmg.net/PDFLibrary/Duchenne-Becker-Muscular-Dystrophy.pdf</URL>
                    <CitationText>American College of Medical Genetics &amp;amp; Genomics Genetic Testing ACT Sheet, Duchenne and Becker Muscular Dystrophy, 2012</CitationText>
                  </Citation>
                  <XRef ID="98896" DB="Orphanet" />
                  <XRef ID="C0013264" DB="MedGen" />
                  <XRef ID="MONDO:0010679" DB="MONDO" />
                  <XRef Type="MIM" ID="310200" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="11234" DB="ClinVar" />
          <XRef ID="CA412652981" DB="ClinGen" />
          <XRef ID="DMD_000062" DB="LOVD 3" />
          <XRef Type="Allelic variant" ID="300377.0024" DB="OMIM" />
          <XRef Type="rs" ID="398123828" DB="dbSNP" />
        </XRefList>
      </SimpleAllele>
      <Name>NM_004006.3(DMD):c.[10086+1G&gt;T;10126del]</Name>
      <VariationType>Haplotype</VariationType>
      <OtherNameList>
        <Name>DMD, 1-BP DEL, 10334C AND IVS69, G-T, +1</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression MANESelect="true">
            <Expression>NM_004006.3:c.[10086+1G&gt;T;10126del]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300377.0024" DB="OMIM" />
      </XRefList>
    </Haplotype>
    <RCVList>
      <RCVAccession Title="NM_004006.3(DMD):c.[10086+1G&gt;T;10126del] AND Duchenne muscular dystrophy" Accession="RCV000011985" Version="16">
        <ClassifiedConditionList TraitSetID="3094">
          <ClassifiedCondition DB="MedGen" ID="C0013264">Duchenne muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-07-06" MostRecentSubmission="2023-03-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Emery, A. E. H. Duchenne Muscular Dystrophy. (2nd ed.) Oxford, UK: Oxford University Press (pub.) 1993.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1483053</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7581396</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8301652</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3094" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10877" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Duchenne muscular dystrophy</ElementValue>
                <XRef ID="Duchenne+Muscular+Dystrophy/2340" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010679" DB="MONDO" />
                <XRef ID="76670001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, pseudohypertrophic progressive, Duchenne type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DMD</ElementValue>
                <XRef Type="MIM" ID="310200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6291" />
                <XRef ID="6291" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and DMD-associated dilated cardiomyopathy (DCM). The mild end of the spectrum includes the phenotypes of asymptomatic increase in serum concentration of creatine phosphokinase (CK) and muscle cramps with myoglobinuria. The severe end of the spectrum includes progressive muscle diseases that are classified as Duchenne/Becker muscular dystrophy when skeletal muscle is primarily affected and as DMD-associated DCM when the heart is primarily affected. Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently and standing up from a supine position. Proximal weakness causes a waddling gait and difficulty climbing stairs, running, jumping, and standing up from a squatting position. DMD is rapidly progressive, with affected children being wheelchair dependent by age 12 years. Cardiomyopathy occurs in almost all individuals with DMD after age 18 years. Few survive beyond the third decade, with respiratory complications and progressive cardiomyopathy being common causes of death. Becker muscular dystrophy (BMD) is characterized by later-onset skeletal muscle weakness. With improved diagnostic techniques, it has been recognized that the mild end of the spectrum includes men with onset of symptoms after age 30 years who remain ambulatory even into their 60s. Despite the milder skeletal muscle involvement, heart failure from DCM is a common cause of morbidity and the most common cause of death in BMD. Mean age of death is in the mid-40s. DMD-associated DCM is characterized by left ventricular dilation and congestive heart failure. Females heterozygous for a DMD pathogenic variant are at increased risk for DCM.</Attribute>
                <XRef ID="NBK1119" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="general" Abbrev="Updated, AAN/CNS, 2005">
                <ID Source="PubMed">15642897</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2005">
                <ID Source="PubMed">16322188</ID>
              </Citation>
              <Citation Type="general" Abbrev="DMD Management and Anesthesia - ACCP, 2007">
                <ID Source="PubMed">18079231</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                <ID Source="PubMed">19945913</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2010">
                <ID Source="PubMed">19945914</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301298</ID>
                <ID Source="BookShelf">NBK1119</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC Respiratory Panel, 2010">
                <ID Source="PubMed">20597083</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_DuchenneMuscularDystrophy-enPro13913.pdf</URL>
                <CitationText>Orphanet, Duchenne muscular dystrophy, 2013</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2022">
                <ID Source="PubMed">26833937</ID>
                <ID Source="pmc">4773944</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29395990</ID>
                <ID Source="pmc">5889091</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29398641</ID>
                <ID Source="pmc">5902408</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC DMD Care Considerations Working Group, 2018">
                <ID Source="PubMed">29395989</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/DMD_Pathogenic_Variants.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Pathogenic Variant in Dystrophin (DMD Gene) and elevated creatine kinase muscle isoform (CK-MM), Duchenne and Becker Muscular Dystrophy, 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_CKMM.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated creatine kinase muscle isoform (CKMM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/DMD-Elevated-CKMM-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, ELEVATED CREATINEKINASE(CK)-MM , Genetic Neuromuscular Disorders, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2020">
                <URL>https://www.acmg.net/PDFLibrary/DMD_No_Pathogenic_Variant.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, No Pathogenic Variant in Dystrophin (DMD) Gene after elevated creatine kinase muscle isoform (CK-MM), Genetic Neuromuscular Disease, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Duchenne-Becker-Muscular-Dystrophy.pdf</URL>
                <CitationText>American College of Medical Genetics &amp;amp; Genomics Genetic Testing ACT Sheet, Duchenne and Becker Muscular Dystrophy, 2012</CitationText>
              </Citation>
              <XRef ID="98896" DB="Orphanet" />
              <XRef ID="C0013264" DB="MedGen" />
              <XRef ID="MONDO:0010679" DB="MONDO" />
              <XRef Type="MIM" ID="310200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32219" SubmissionDate="2017-07-03" DateLastUpdated="2023-03-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300377.0024_DUCHENNE MUSCULAR DYSTROPHY" title="DMD, 1-BP DEL, 10334C AND IVS69, G-T, +1_DUCHENNE MUSCULAR DYSTROPHY" />
        <ClinVarAccession Accession="SCV000032219" DateUpdated="2023-03-18" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Using single-strand conformation analysis of products amplified by PCR to screen the terminal domains of the DMD gene (exons 60-79) of 20 unrelated patients with Duchenne muscular dystrophy (DMD; 310200) or Becker muscular dystrophy (BMD; 300376), Tuffery et al. (1995) detected 2 novel point mutations in 2 DMD patients with mental retardation: a 1-bp deletion in exon 70 (which they called 10334delC) and a 5-prime splice donor site alteration in intron 69 (10294,+1,G-T). Both mutations were predicted to result in premature translation termination of dystrophin. Mental retardation is observed in about 30% of patients with DMD (Emery, 1993). This study added 2 more cases to the series of 5 patients out of 7 with a C-terminal point mutation associated with mental retardation described by Lenk et al. (1993), suggesting a possible involvement of the terminal region of the gene in cognitive impairment. Hodgson et al. (1992) found that the same deletion in different individuals occurred with or without mental impairment and that many different deletions are associated with mental retardation.</Attribute>
              <Citation>
                <ID Source="PubMed">7581396</ID>
              </Citation>
              <Citation>
                <CitationText>Emery, A. E. H. Duchenne Muscular Dystrophy. (2nd ed.) Oxford, UK: Oxford University Press (pub.) 1993.</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">8301652</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1483053</ID>
              </Citation>
              <XRef DB="OMIM" ID="310200" Type="MIM" />
              <XRef DB="OMIM" ID="300376" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DMD" />
          </GeneList>
          <Name>DMD, 1-BP DEL, 10334C AND IVS69, G-T, +1</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 10334C AND IVS69, G-T, +1</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300377.0024" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DUCHENNE MUSCULAR DYSTROPHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32219" TraitType="Disease" MappingType="Name" MappingValue="DUCHENNE MUSCULAR DYSTROPHY" MappingRef="Preferred">
        <MedGen CUI="C0013264" Name="Duchenne muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

